The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region

Journal of Clinical Investigation

Volumn 121, Issue 3, 2011, Pages 1174-1190

  Herrero, Raquel ^a   Kajikawa, Osamu ^a   Matute Bello, Gustavo ^a   Wang, Yi ^a,b   Hagimoto, Naoki ^a   Mongovin, Steve ^a   Wong, Venus ^a   Park, David R ^a   Brot, Nathan ^c   Heinecke, Jay W ^d   Rosen, Henry ^d   Goodman, Richard B ^a   Fu, Xiaoyun ^a,b   Martin, Thomas R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MATRILYSIN; METHIONINE; MYELOPEROXIDASE; OXIDIZING AGENT; PROTEINASE;

ACUTE LUNG INJURY; ADULT; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVATION; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOLECULAR WEIGHT; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE;

ANIMALS; APOPTOSIS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; DNA DAMAGE; FAS LIGAND PROTEIN; HUMANS; HYDROGEN PEROXIDE; LUNG; MATRIX METALLOPROTEINASE 7; METHIONINE; MICE; OXIDANTS; OXYGEN; PROTEIN STRUCTURE, TERTIARY;

EID: 79952208093     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI43004     Document Type: Article

References (58)

1. Rubenfeld GD, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685-1693. (Pubitemid 41464707)
2. Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med. 1982;3(1):35-56. (Pubitemid 12062058)
3. Matthay MA, Robriquet L, Fang X. Alveolar epithelium: role in lung fluid balance and acute lung injury. Proc Am Thorac Soc. 2005;2(3):206-213. (Pubitemid 41500847)
4. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2(7511):319-323.
5. Bardales RH, Xie SS, Schaefer RF, Hsu SM. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol. 1996;149(3):845-852. (Pubitemid 26334168)
6. Martin TR, Hagimoto N, Nakamura M, Matute-Bello G. Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc. 2005;2(3):214-220. (Pubitemid 41500848)
7. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol. 2008;294(4):L632-L641. (Pubitemid 351520095)
8. Matute-Bello G, et al. Essential role of MMP-12 in Fas-induced lung fibrosis. Am J Respir Cell Mol Biol. 2007;37(2):210-221. (Pubitemid 47255004)
9. Matute-Bello G, et al. Fas-mediated acute lung injury requires fas expression on nonmyeloid cells of the lung. J Immunol. 2005;175(6):4069-4075. (Pubitemid 41292070)
10. Matute-Bello G, et al. Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol. 2001;281(2):L328-L335.
11. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR, Liles WC. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol. 2001;158(1):153-161. (Pubitemid 32096480)
12. Imamura R, et al. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem. 2004;279(45):46415-46423. (Pubitemid 39518283)
13. Ponton A, Clement MV, Stamenkovic I. The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function. J Biol Chem. 1996;271(15):8991-8995. (Pubitemid 26123328)
14. Hagimoto N, et al. Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation. Am J Respir Cell Mol Biol. 1999;21(3):436-445. (Pubitemid 129517199)
15. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993;75(6):1169-1178. (Pubitemid 24006113)
16. Nagata S, Golstein P. The Fas death factor. Science. 1995;267(5203):1449- 1456.
17. Itoh N, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66(2):233-243. (Pubitemid 121001362)
18. Orlinick JR, Elkon KB, Chao MV. Separate domains of the human Fas ligand dictate self-association and receptor binding. J Biol Chem. 1997;272(51):32221- 32229. (Pubitemid 28011899)
19. Schulte M, et al. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 2007;14(5):1040-1049. (Pubitemid 46629842)
20. Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys. 2002;408(2):155-161. (Pubitemid 36027034)
21. Kiener PA, et al. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J Immunol. 1997;159(4):1594-1598. (Pubitemid 127484141)
22. Berg D, et al. Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L. Cell Death Differ. 2007;14(12):2021-2034.
23. Schneider P, et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med. 1998;187(8):1205-1213. (Pubitemid 28189110)
24. Holler N, et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol. 2003;23(4):1428-1440. (Pubitemid 36177050)
25. Shiraishi T, et al. Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif. Biochem Biophys Res Commun. 2004;322(1):197-202. (Pubitemid 39093857)
26. Matute-Bello G, et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol. 1999;163(4):2217-2225. (Pubitemid 29382230)
27. Matthay MA, Geiser T, Matalon S, Ischiropoulos H. Oxidant-mediated lung injury in the acute respiratory distress syndrome. Crit Care Med. 1999;27(9):2028-2030. (Pubitemid 29455146)
28. Fink MP. Role of reactive oxygen and nitrogen species in acute respiratory distress syndrome. Curr Opin Crit Care. 2002;8(1):6-11. (Pubitemid 34165522)
29. Gole MD, et al. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2000;278(5):L961-L967. (Pubitemid 30351051)
30. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet. 1986;1(8471):11-14.
31. Sittipunt C, et al. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163(2):503-510. (Pubitemid 32158537)
32. Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem. 2001;276(44):41279-41287.
33. Stadtman ER, Moskovitz J, Levine RL. Oxidation of methionine residues of proteins: biological consequences. Antioxid Redox Signal. 2003;5(5):577-582. (Pubitemid 37315145)
34. Zhu S, Ware LB, Geiser T, Matthay MA, Matalon S. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med. 2001;163(1):166-172. (Pubitemid 32097973)
35. Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J Biol Chem. 2003;278(31):28403-28409. (Pubitemid 36935741)
36. Pitt AR, Spickett CM. Mass spectrometric analysis of HOCl- and free-radical-induced damage to lipids and proteins. Biochem Soc Trans. 2008;36(pt 5):1077-1082.
37. Shechter Y. Selective oxidation and reduction of methionine residues in peptides and proteins by oxygen exchange between sulfoxide and sulfide. J Biol Chem. 1986;261(1):66-70. (Pubitemid 16144812)
38. Albertine KH, et al. Fas and Fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol. 2002;161(5):1783-1796. (Pubitemid 35265536)
39. Hashimoto S, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, Nakajima H. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000;161(1):237-243. (Pubitemid 30055931)
40. Mizuta M, et al. Fas ligand released by activated monocytes causes apoptosis of lung epithelial cells in human acute lung injury model in vitro. Biol Pharm Bull. 2008;31(3):386-390. (Pubitemid 351442132)
41. Nakamura M, et al. Differential response of human lung epithelial cells to fas-induced apoptosis. Am J Pathol. 2004;164(6):1949-1958. (Pubitemid 38669344)
42. Kitamura Y, et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med. 2001;163(3 pt 1):762-769. (Pubitemid 32230841)
43. Tateda K, et al. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J Immunol. 2003;170(8):4209-4216. (Pubitemid 36428187)
44. Neff TA, et al. Relationship of acute lung inflammatory injury to Fas/FasL system. Am J Pathol. 2005;166(3):685-694. (Pubitemid 40315626)
45. Perl M, et al. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med. 2007;176(6):591-601. (Pubitemid 47403277)
46. Fine A, Anderson NL, Rothstein TL, Williams MC, Gochuico BR. Fas expression in pulmonary alveolar type II cells. Am J Physiol. 1997;273(1 pt 1):L64-L71.
47. Fligiel SE, et al. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum Pathol. 2006;37(4):422-430.
48. Levine RL, Berlett BS, Moskovitz J, Mosoni L, Stadtman ER. Methionine residues may protect proteins from critical oxidative damage. Mech Ageing Dev. 1999;107(3):323-332. (Pubitemid 29210232)
49. Levine RL, Moskovitz J, Stadtman ER. Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life. 2000;50(4-5):301-307. (Pubitemid 32289088)
50. Vogt W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol Med. 1995;18(1):93-105.
51. Stadtman ER, Van Remmen H, Richardson A, Wehr NB, Levine RL. Methionine oxidation and aging. Biochim Biophys Acta. 2005;1703(2):135-140. (Pubitemid 40170436)
52. Fransson JR. Oxidation of human insulin-like growth factor I in formulation studies. 3. Factorial experiments of the effects of ferric ions, EDTA, and visible light on methionine oxidation and covalent aggregation in aqueous solution. J Pharm Sci. 1997;86(9):1046-1050. (Pubitemid 27382908)
53. Siegel RM, et al. SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane. J Cell Biol. 2004;167(4):735-744. (Pubitemid 39565153)
54. Henkler F, et al. The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. J Cell Biol. 2005;168(7):1087-1098.
55. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME. Molecular ordering of the initial signaling events of CD95. Mol Cell Biol. 2002;22(1):207-220. (Pubitemid 33144269)
56. Cheng J, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263(5154):1759-1762. (Pubitemid 24131584)
57. Wortinger MA, et al. Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue. Immunology. 2003;110(2):225-233. (Pubitemid 37249262)
58. Matute-Bello G, et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997;156(6):1969-1977.